The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease

[1]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[2]  G. Lefranc,et al.  Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms , 2011, Experimental lung research.

[3]  Lilah M. Besser,et al.  Regional Variation in Health Status among Chronic Obstructive Pulmonary Disease Patients , 2010, Respiration.

[4]  T. To,et al.  Trends in chronic obstructive pulmonary disease prevalence, incidence, and mortality in ontario, Canada, 1996 to 2007: a population-based study. , 2010, Archives of internal medicine.

[5]  Anand A. Dalal,et al.  Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population. , 2009, Chest.

[6]  A. Pickard,et al.  Medication adherence and persistence in the last year of life in COPD patients. , 2009, Respiratory medicine.

[7]  W. MacNee,et al.  Update in chronic obstructive pulmonary disease 2008. , 2009, American journal of respiratory and critical care medicine.

[8]  T. To,et al.  Identifying Individuals with Physcian Diagnosed COPD in Health Administrative Databases , 2009, COPD.

[9]  Richard Baumgartner,et al.  Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. , 2008, Journal of clinical epidemiology.

[10]  C. Camargo,et al.  National study of emergency department visits for acute exacerbation of chronic obstructive pulmonary disease, 1993-2005. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[11]  C. Camargo,et al.  Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department. , 2008, Joint Commission journal on quality and patient safety.

[12]  P. Camp,et al.  The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia. , 2008, Canadian respiratory journal.

[13]  A. Pickard,et al.  Risk for Death Associated with Medications for Recently Diagnosed Chronic Obstructive Pulmonary Disease , 2008, Annals of Internal Medicine.

[14]  J Stocks,et al.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.

[15]  Anand A. Dalal,et al.  Burden of concomitant asthma and COPD in a Medicaid population. , 2008, Chest.

[16]  W. MacNee,et al.  Update in chronic obstructive pulmonary disease 2007. , 2008, American journal of respiratory and critical care medicine.

[17]  G. Washko,et al.  The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. , 2008, American journal of respiratory and critical care medicine.

[18]  M. Young,et al.  Health services research , 2008, Journal of General Internal Medicine.

[19]  J. Curtis,et al.  Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. , 2007, Archives of internal medicine.

[20]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[21]  Russell Mardon,et al.  Spirometry utilization for COPD: how do we measure up? , 2007, Chest.

[22]  C. Blanchette,et al.  PRS1 BURDEN OF CONCOMITANT ASTHMA AND COPD IN A MEDICAID POPULATION , 2007 .

[23]  D. Au,et al.  Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[24]  Edward M. Omron.  Inhaled corticosteroids and mortality in COPD. , 2007, Chest.

[25]  D. Mannino,et al.  Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.

[26]  F. Frost,et al.  An Algorithm for the Identification of Undiagnosed COPD Cases Using Administrative Claims Data , 2006 .

[27]  K. Weiss,et al.  Spirometry use in clinical practice following diagnosis of COPD. , 2006, Chest.

[28]  D. Roblin,et al.  Survival of COPD patients using inhaled corticosteroids and long-acting beta agonists. , 2006, Respiratory medicine.

[29]  C. D. Mathers,et al.  Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.

[30]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[31]  Y. Lacasse,et al.  The validity of diagnosing chronic obstructive pulmonary disease from a large administrative database. , 2005, Canadian respiratory journal.

[32]  C. Lemière,et al.  A cohort study showed that health insurance databases were accurate to distinguish chronic obstructive pulmonary disease from asthma and classify disease severity. , 2005, Journal of clinical epidemiology.

[33]  S. Jain,et al.  Assessing the Accuracy of Administrative Data in Health Information Systems , 2004, Medical care.

[34]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[35]  A. Boyle,et al.  Update on chronic obstructive pulmonary disease. , 2004, Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses.

[36]  D E Grobbee,et al.  External validation is necessary in prediction research: a clinical example. , 2003, Journal of clinical epidemiology.

[37]  B. Celli,et al.  Population impact of different definitions of airway obstruction , 2003, European Respiratory Journal.

[38]  A. Iqbal,et al.  Interpreting COPD prevalence estimates: what is the true burden of disease? , 2003, Chest.

[39]  Harold Alan Pincus,et al.  The most expensive medical conditions in America. , 2002, Health affairs.

[40]  J. Tu,et al.  Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[41]  J. Habbema,et al.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. , 2001, Journal of clinical epidemiology.

[42]  D. Tashkin,et al.  Gender bias in the diagnosis of COPD. , 2001, Chest.

[43]  G. Clermont,et al.  Predicting hospital mortality for patients in the intensive care unit: A comparison of artificial neural networks with logistic regression models , 2001, Critical care medicine.

[44]  Sheryl M Davies,et al.  AHRQ Quality Indicators Guide to Prevention Quality Indicators : Hospital Admission for Ambulatory Care Sensitive Conditions , 2001 .

[45]  P. Barnes,et al.  Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[46]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[47]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[48]  J V Tu,et al.  Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. , 1996, Journal of clinical epidemiology.

[49]  N S Rawson,et al.  Validity of the recording of ischaemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. , 1995, Statistics in medicine.

[50]  K. Chapman,et al.  Physician perceptions and management of COPD. , 1993, Chest.

[51]  H. Akaike,et al.  Information Theory and an Extension of the Maximum Likelihood Principle , 1973 .